| Year |
Citation |
Score |
| 2009 |
Ho SK, Perez EE, Rose SL, Coman RM, Lowe AC, Hou W, Ma C, Lawrence RM, Dunn BM, Sleasman JW, Goodenow MM. Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor. Aids (London, England). 23: 1631-40. PMID 19625947 DOI: 10.1097/Qad.0B013E32832E0599 |
0.678 |
|
| 2008 |
Ho SK, Coman RM, Bunger JC, Rose SL, O'Brien P, Munoz I, Dunn BM, Sleasman JW, Goodenow MM. Drug-associated changes in amino acid residues in Gag p2, p7(NC), and p6(Gag)/p6(Pol) in human immunodeficiency virus type 1 (HIV-1) display a dominant effect on replicative fitness and drug response. Virology. 378: 272-81. PMID 18599104 DOI: 10.1016/J.Virol.2008.05.029 |
0.647 |
|
| 2003 |
Goodenow MM, Rose SL, Tuttle DL, Sleasman JW. HIV-1 fitness and macrophages. Journal of Leukocyte Biology. 74: 657-66. PMID 12960234 DOI: 10.1189/Jlb.0403186 |
0.625 |
|
| 2002 |
Goodenow MM, Bloom G, Rose SL, Pomeroy SM, O'Brien PO, Perez EE, Sleasman JW, Dunn BM. Naturally occurring amino acid polymorphisms in human immunodeficiency virus type 1 (HIV-1) Gag p7(NC) and the C-cleavage site impact Gag-Pol processing by HIV-1 protease. Virology. 292: 137-49. PMID 11878916 DOI: 10.1006/Viro.2001.1184 |
0.63 |
|
| 2001 |
Perez EE, Rose SL, Peyser B, Lamers SL, Burkhardt B, Dunn BM, Hutson AD, Sleasman JW, Goodenow MM. Human immunodeficiency virus type 1 protease genotype predicts immune and viral responses to combination therapy with protease inhibitors (PIs) in PI-naive patients. The Journal of Infectious Diseases. 183: 579-88. PMID 11170983 DOI: 10.1086/318538 |
0.571 |
|
| Show low-probability matches. |